Who owns GILEAD SCIENCES, INC. (GILD)? Elite investor 13F holders

10 tracked elite investors reported holding GILEAD SCIENCES, INC as of 2026-06-30, including Dodge & Cox Funds, Renaissance Technologies LLC, D.E. Shaw, Gotham Asset Management, Bridgewater Associates. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

10 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
Dodge & Cox FundsGILEAD SCIENCES INCSHARE2026-06-302026-08-13 00:00:002991423815.00 USD23677567.000000SharesreduceOriginal filing
Renaissance Technologies LLCGILEAD SCIENCES INCSHARE2026-06-302026-08-13 00:00:00280143284.00 USD2217376.000000SharesaddOriginal filing
D.E. ShawGILEAD SCIENCES INCSHARE2026-06-302026-08-14 00:00:00289923642.00 USD2294789.000000SharesaddOriginal filing
Gotham Asset ManagementGILEAD SCIENCES INCSHARE2026-06-302026-08-14 00:00:0048243055.00 USD381851.000000SharesaddOriginal filing
Bridgewater AssociatesGILEAD SCIENCES INCSHARE2026-06-302026-08-14 00:00:0036749906.00 USD290881.000000SharesaddOriginal filing
Ariel InvestmentsGILEAD SCIENCES INCSHARE2026-06-302026-08-14 00:00:0024719305.00 USD195657.000000SharesreduceOriginal filing
Ancora Advisors / Ancora HoldingsGILEAD SCIENCES INCSHARE2026-06-302026-08-14 00:00:0015345866.00 USD121465.000000SharesreduceOriginal filing
Tudor InvestmentGILEAD SCIENCES INCSHARE2026-06-302026-08-14 00:00:009462361.00 USD74896.000000SharesaddOriginal filing
GMOGILEAD SCIENCES INCSHARE2026-06-302026-08-13 00:00:001997562.00 USD15811.000000SharesreduceOriginal filing
Mairs & Power FundsGILEAD SCIENCES INCSHARE2026-06-302026-08-14 00:00:00287424.00 USD2275.000000SharesholdOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown